documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
16 rows where docket_id = "FDA-2001-D-0219" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 16
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2001-D-0219-0015 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Use of Data Monitoring Committees in Clinical Trials; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request | Notice | Notice of Availability | 2024-02-13T05:00:00Z | 2024 | 2 | 2024-02-13T14:42:27Z | 2024-02849 | 0 | 0 | 0900006486404168 | ||
| FDA-2001-D-0219-0016 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft Guidance | Other | Guidance | 2024-02-13T05:00:00Z | 2024 | 2 | 2024-02-13T05:00:00Z | 2024-04-16T03:59:59Z | 2025-06-06T09:00:07Z | 1 | 0 | 0900006486404548 | |
| FDA-2001-D-0219-0014 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Tab E - Tab E-Guidance for Industry, ICR E6, Good Clinica1 Practice: Consolidated Guidance, April 1996 [Guidance of 3/28/2006] | Supporting & Related Material | BKG-Background Material | 2010-05-10T04:00:00Z | 2010 | 5 | 2010-05-10T20:08:54Z | 0 | 0 | 09000064804e4eb3 | |||
| FDA-2001-D-0219-0013 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Tab D - Guidance for Industry, ICH E9, Statistical Principles forClinical Trials, September 1998 [Guidance of 3/28/2006] | Supporting & Related Material | BKG-Background Material | 2010-05-10T04:00:00Z | 2010 | 5 | 2010-05-10T20:08:52Z | 0 | 0 | 09000064804e4eac | |||
| FDA-2001-D-0219-0010 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Clinical Trial Sponsors on the Establishment & Operation of Clinical Trial Monitoring Committees, November 2201 - Draft Guidance | Supporting & Related Material | GDL-Guidance | 2010-05-10T04:00:00Z | 2010 | 5 | 2010-05-10T18:54:00Z | 0 | 0 | 09000064804e4dee | |||
| FDA-2001-D-0219-0011 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | List of References [Guidance for Clinical Trial SponsorsEstablishment & Operation of Clinical Trial Monitoring Committees 3/28/2006] | Supporting & Related Material | BKG-Background Material | 2010-05-10T04:00:00Z | 2010 | 5 | 2010-05-10T19:48:22Z | 0 | 0 | 09000064804e4ea1 | |||
| FDA-2001-D-0219-0012 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Tab C - DHHS, Finaneial Relationships and Interests in Research Involving Human Subjects: Guidance for Human Subject Protection May 5, 2004. [Guidance of 3/28/2006] | Supporting & Related Material | BKG-Background Material | 2010-05-10T04:00:00Z | 2010 | 5 | 2010-05-10T19:45:19Z | 0 | 0 | 09000064804e4ea3 | |||
| FDA-2001-D-0219-0009 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees | Notice | NAL-Notice of Approval | 2006-07-31T04:00:00Z | 2006 | 7 | 2006-07-28T04:00:00Z | 2010-05-10T16:54:40Z | 0 | 0 | 09000064804e4ed0 | ||
| FDA-2001-D-0219-0007 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Supporting Statement | Supporting & Related Material | SS-Supporting Statement | 2006-07-31T04:00:00Z | 2006 | 7 | 2008-04-25T02:28:20Z | 0 | 0 | 09000064804e4ecb | |||
| FDA-2001-D-0219-0008 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Supporting Statement | Supporting & Related Material | SS-Supporting Statement | 2006-07-31T04:00:00Z | 2006 | 7 | 2008-04-25T02:28:19Z | 0 | 0 | 09000064804e4ece | |||
| FDA-2001-D-0219-0005 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability | Notice | NAD-Notice of Availability of Data | 2006-03-28T05:00:00Z | 2006 | 3 | 2006-03-27T05:00:00Z | 2010-05-10T16:50:29Z | 0 | 0 | 09000064804e4ec0 | ||
| FDA-2001-D-0219-0006 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committees, March 2006 | Supporting & Related Material | GDL-Guidance | 2006-03-28T05:00:00Z | 2006 | 3 | 2010-05-10T20:21:50Z | 0 | 0 | 09000064804e4ec4 | |||
| FDA-2001-D-0219-0003 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committee December 2005 - Draft Guidance | Supporting & Related Material | GDL-Guidance | 2006-01-10T05:00:00Z | 2006 | 1 | 2010-05-10T18:57:16Z | 0 | 0 | 09000064804e4e9c | |||
| FDA-2001-D-0219-0004 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Agency Information Collection Activities; Submission for Office | Notice | N-Notice | 2006-01-10T05:00:00Z | 2006 | 1 | 2010-05-10T16:43:43Z | 0 | 0 | 09000064804e4e9e | |||
| FDA-2001-D-0219-0002 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability | Notice | NAD-Notice of Availability of Data | 2001-11-20T05:00:00Z | 2001 | 11 | 2001-11-19T05:00:00Z | 2002-02-20T04:59:59Z | 2010-05-10T16:34:55Z | 0 | 0 | 09000064804e4e02 | |
| FDA-2001-D-0219-0001 | FDA | Establishment & Operation of Clinical Trial Monitoring Comm FDA-2001-D-0219 | Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting | Notice | NM-Notice of Meeting | 2001-11-05T05:00:00Z | 2001 | 11 | 2010-05-10T16:33:19Z | 0 | 0 | 09000064804e4d7b |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);